Program Schedule

PK/PD Studies

Thursday, October 9, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Target Audience: Academicians, Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Researchers, Scientists

Vancomycin Dosing and Concentrations at a Large University-Affiliated County Hospital
Gilmer Youn, MD ; Emi Minejima, PharmD ; Lironn Kraler, BS ; Brenda Jones, MD ; Michael Neely, MD
  • IDWeek poster final.pdf (365.8 kB)
  • 393
    Vancomycin Dosing in Obese Patients
    Mohammed Alquwaizani, PharmD ; David W. Kubiak, PharmD ; David Sansonetti ; Megan Barra ; Michael S. Calderwood, MD, MPH
    Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
    Shouichi Shiotsuka ; Tohru Takata, MD, PhD ; Atsushi Togawa ; Yasushi Takamatsu ; Kazuo Tamura, MD
    What is the Best Predictor for Vancomycin Nephrotoxicity?
    Kassem Hammoud, MD ; Neil Goodloe, MD ; Wael Haidar, MD ; Michael Brimacombe, PhD ; Wissam El Atrouni, MD
  • Vancposter1.pdf (824.8 kB)
  • 398
    Pharmacokinetics of dalbavancin (DAL) in bone and associated tissues in patients undergoing orthopedic surgical procedures
    James Baldassarre, MD ; Scott Van Wart, M.S. ; Alan Forrest, PharmD ; Christopher Rubino, Pharm D ; Michael Dunne, MD
    Beyond the Antibiogram: Using Monte Carlo Analysis to Optimize Institution-Specific Antipseudomonal Therapy
    Sarah Tennant, PharmD ; Jeffrey M. Rybak, PharmD ; Donna R. Burgess, RPh ; David S. Burgess, PharmD, FCCP ; Craig Martin, PharmD
  • IDweek-3.pdf (431.7 kB)
  • 402
    Pharmacokinetics of Extended Versus Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
    Frédéric Frippiat, MD ; Laurence Seidel ; Raphael Denooz, PhD ; Pierre Damas, MD, PhD ; Nathalie Layios, MD ; Michel Moutschen, MD, PhD
  • IDWeek 2014 Poster final.pdf (526.6 kB)
  • 405
    Risk of gentamicin vestibulotoxicity with different dosing regimens:  a retrospective cohort study
    Jerome Leis, MD, MSc ; David Pothier, MBChB, MSc ; Wayne Gold, MD ; John Rutka, MD
    Pharmacokinetic modeling of linezolid dosing regimens for multidrug resistant tuberculosis
    Pennan Barry, MD, MPH ; Daniel Deck, PharmD ; Andras Farkas, PharmD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, All Rights Reserved.

    Follow IDWeek